$92.57
1.481.62%
At close: -
$92.56
-0.01000-0.01%
After Hours: Dec 20, 7:48 PM EDT
Gilead Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Gilead Sciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $2.02 | $1.55 | 30.3 % |
Jun 2024 | 2024-08-08 | $2.01 | $1.60 | 25.6 % |
Mar 2024 | 2024-04-25 | $-1.32 | $-1.49 | 11.4 % |
Dec 2023 | 2024-02-06 | $1.72 | $1.78 | -3.37 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $7.55B | $7.00B | 7.79 % |
Jun 2024 | 2024-08-08 | $6.95B | $6.72B | 3.48 % |
Mar 2024 | 2024-04-25 | $6.69B | $6.34B | 5.46 % |
Dec 2023 | 2024-02-06 | $7.12B | $7.09B | 0.35 % |
Gilead Sciences (GILD) is scheduled to report earnings on February 11, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $2.02, which beat the estimate of $1.55.
The Actual Revenue was $7.5B, which beat the estimate of $7B.
Browse earnings estimates, EPS, and revenue on all stocks.